Willis Investment Counsel Increased Its Stake in Ca (CA) as Stock Declined; Thompson Rubinstein Investment Management Cut Its Bruker (BRKR) Stake by $958,290; Market Value Declined

April 22, 2018 - By Nellie Frank

Bruker Corporation (NASDAQ:BRKR) Logo

Willis Investment Counsel increased its stake in Ca Inc (CA) by 2.06% based on its latest 2017Q4 regulatory filing with the SEC. Willis Investment Counsel bought 9,900 shares as the company’s stock declined 0.27% with the market. The institutional investor held 491,100 shares of the prepackaged software company at the end of 2017Q4, valued at $16.34 million, up from 481,200 at the end of the previous reported quarter. Willis Investment Counsel who had been investing in Ca Inc for a number of months, seems to be bullish on the $14.42 billion market cap company. The stock decreased 0.75% or $0.26 during the last trading session, reaching $34.58. About 1.58M shares traded. CA, Inc. (NASDAQ:CA) has risen 5.46% since April 22, 2017 and is uptrending. It has underperformed by 6.09% the S&P500.

Thompson Rubinstein Investment Management Inc decreased its stake in Bruker Corporation (BRKR) by 17.33% based on its latest 2017Q4 regulatory filing with the SEC. Thompson Rubinstein Investment Management Inc sold 28,185 shares as the company’s stock declined 13.70% with the market. The institutional investor held 134,447 shares of the laboratory analytical instruments company at the end of 2017Q4, valued at $4.61 million, down from 162,632 at the end of the previous reported quarter. Thompson Rubinstein Investment Management Inc who had been investing in Bruker Corporation for a number of months, seems to be less bullish one the $4.78 billion market cap company. The stock increased 1.39% or $0.42 during the last trading session, reaching $30.66. About 668,852 shares traded or 17.47% up from the average. Bruker Corporation (NASDAQ:BRKR) has risen 29.39% since April 22, 2017 and is uptrending. It has outperformed by 17.84% the S&P500.

Investors sentiment is 1.16 in Q4 2017. Its the same as in 2017Q3. It has no change, as 32 investors sold CA shares while 143 reduced holdings. only 54 funds opened positions while 149 raised stakes. 270.11 million shares or 2.83% less from 277.99 million shares in 2017Q3 were reported. Hartford Inv Mngmt stated it has 122,469 shares. Td Asset Mgmt reported 303,841 shares stake. Tocqueville Asset Mngmt Limited Partnership holds 94,415 shares. Gideon Capital Advsrs Inc owns 0.21% invested in CA, Inc. (NASDAQ:CA) for 7,170 shares. Guinness Atkinson Asset Management invested in 0.14% or 6,810 shares. Moreover, Eii Mngmt has 0.75% invested in CA, Inc. (NASDAQ:CA) for 53,150 shares. Catawba Management Va reported 11,740 shares. Andra Ap, a Alabama-based fund reported 77,000 shares. Clinton Group Inc Inc owns 171,154 shares. Cornercap Invest Counsel reported 0.58% of its portfolio in CA, Inc. (NASDAQ:CA). Northern Corporation accumulated 5.31 million shares or 0.04% of the stock. Paloma Ptnrs holds 0.01% or 11,594 shares in its portfolio. San Francisco Sentry (Ca) stated it has 352 shares. Cadence Cap Lc invested in 28,197 shares or 0.06% of the stock. Endurance Wealth Mngmt reported 1,819 shares or 0.01% of all its holdings.

Since March 9, 2018, it had 0 buys, and 2 sales for $3.25 million activity. FLAHERTY LAUREN PATRICIA sold $396,643 worth of stock or 10,793 shares.

Willis Investment Counsel, which manages about $1.45 billion and $1.42B US Long portfolio, decreased its stake in Dolby Laboratories Inc Cl A (NYSE:DLB) by 61,540 shares to 149,275 shares, valued at $9.26M in 2017Q4, according to the filing. It also reduced its holding in Intl Flavors & Fragrance (NYSE:IFF) by 10,425 shares in the quarter, leaving it with 46,878 shares, and cut its stake in Fastenal Co (NASDAQ:FAST).

Among 16 analysts covering CA Technologies (NASDAQ:CA), 2 have Buy rating, 4 Sell and 10 Hold. Therefore 13% are positive. CA Technologies had 38 analyst reports since August 6, 2015 according to SRatingsIntel. As per Wednesday, January 31, the company rating was maintained by Jefferies. TheStreet downgraded the stock to “Hold” rating in Friday, October 23 report. The firm has “Equal-Weight” rating given on Thursday, August 3 by Barclays Capital. The rating was maintained by KeyBanc Capital Markets with “Hold” on Sunday, September 17. The rating was upgraded by Barclays Capital on Tuesday, January 12 to “Overweight”. The rating was downgraded by Barclays Capital on Friday, July 15 to “Equal-Weight”. Bernstein maintained the stock with “Sell” rating in Wednesday, June 28 report. The firm has “Buy” rating by Mizuho given on Friday, January 22. The stock has “Hold” rating by RBC Capital Markets on Sunday, September 24. Jefferies maintained CA, Inc. (NASDAQ:CA) on Friday, October 27 with “Buy” rating.

Thompson Rubinstein Investment Management Inc, which manages about $259.90M and $303.75M US Long portfolio, upped its stake in Novartis Ag Spon Adr (NYSE:NVS) by 5,795 shares to 74,866 shares, valued at $6.29 million in 2017Q4, according to the filing.

Analysts await Bruker Corporation (NASDAQ:BRKR) to report earnings on May, 2. They expect $0.23 EPS, up 21.05% or $0.04 from last year’s $0.19 per share. BRKR’s profit will be $35.85 million for 33.33 P/E if the $0.23 EPS becomes a reality. After $0.51 actual EPS reported by Bruker Corporation for the previous quarter, Wall Street now forecasts -54.90% negative EPS growth.

Among 16 analysts covering Bruker (NASDAQ:BRKR), 4 have Buy rating, 2 Sell and 10 Hold. Therefore 25% are positive. Bruker had 47 analyst reports since August 20, 2015 according to SRatingsIntel. The firm has “Underperform” rating by Wells Fargo given on Thursday, July 13. The company was maintained on Wednesday, December 20 by Cowen & Co. Leerink Swann maintained Bruker Corporation (NASDAQ:BRKR) rating on Friday, February 9. Leerink Swann has “Market Perform” rating and $34 target. Jefferies maintained Bruker Corporation (NASDAQ:BRKR) rating on Friday, October 20. Jefferies has “Buy” rating and $35.0 target. The stock of Bruker Corporation (NASDAQ:BRKR) earned “Buy” rating by Jefferies on Friday, June 9. The rating was downgraded by JP Morgan on Wednesday, December 14 to “Neutral”. BTIG Research maintained it with “Buy” rating and $25 target in Thursday, August 20 report. Bank of America upgraded the stock to “Hold” rating in Friday, November 3 report. The stock of Bruker Corporation (NASDAQ:BRKR) earned “Neutral” rating by Citigroup on Friday, November 3. As per Tuesday, September 26, the company rating was initiated by Goldman Sachs.

Investors sentiment increased to 1.16 in 2017 Q4. Its up 0.25, from 0.91 in 2017Q3. It is positive, as 11 investors sold BRKR shares while 75 reduced holdings. 45 funds opened positions while 55 raised stakes. 97.01 million shares or 2.08% less from 99.08 million shares in 2017Q3 were reported. Etrade Cap Mgmt Ltd Llc has invested 0.04% of its portfolio in Bruker Corporation (NASDAQ:BRKR). Tudor Corporation Et Al holds 0.03% or 29,423 shares in its portfolio. Goldman Sachs Group invested in 697,258 shares. Moreover, Sei has 0.01% invested in Bruker Corporation (NASDAQ:BRKR) for 101,922 shares. Fny Managed Accounts Ltd Liability Company reported 0% stake. Segall Bryant & Hamill Ltd invested in 90,640 shares. Thompson Rubinstein Inv Management Or holds 1.52% in Bruker Corporation (NASDAQ:BRKR) or 134,447 shares. State Of Wisconsin Board invested in 20,959 shares. Credit Suisse Ag holds 116,660 shares or 0% of its portfolio. 42,372 are held by Susquehanna Grp Limited Liability Partnership. Northern Corporation reported 0.01% of its portfolio in Bruker Corporation (NASDAQ:BRKR). Jennison Associate Limited Company holds 0% or 35,945 shares in its portfolio. Keybank National Association Oh, a Ohio-based fund reported 35,207 shares. 239,765 were reported by Los Angeles Mgmt And Equity. Leuthold Grp Inc Limited Company has 0.38% invested in Bruker Corporation (NASDAQ:BRKR).

Bruker Corporation (NASDAQ:BRKR) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>